Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fever after immunization: current concepts and improved future scientific understanding.

Katrin S Kohl1, S Michael Marcy, Michael Blum

  • 1Centers for Disease Control and Prevention, National Immunization Program, Atlanta, GA 30333, USA. kkohl@cdc.gov

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|August 13, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concordance Between Maternal and Infant COVID-19 and Influenza Vaccination Status.

Pediatrics·2026
Same author

Adjuvanted vs High-Dose Influenza Vaccines in Older US Adults: A Cluster Randomized Crossover Study.

JAMA network open·2026
Same author

Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025.

MMWR. Morbidity and mortality weekly report·2025
Same author

Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant Women.

Obstetrics and gynecology·2025
Same author

Effectiveness of 5-pertussis-component tetanus, diphtheria, and acellular pertussis (Tdap<sub>5</sub>) vaccination in pregnancy at preventing infant pertussis.

American journal of obstetrics and gynecology·2025
Same author

Effectiveness of 2023-2024 COVID-19 Vaccines in Children in the United States.

Pediatrics·2025

Fever is a common sign of illness and a frequent vaccine side effect. Standardizing fever assessment in vaccine studies will improve understanding of its role and significance.

Area of Science:

  • Clinical Medicine
  • Immunology
  • Public Health

Background:

  • Fever is a common clinical symptom in infectious diseases and a frequent adverse event following immunization (AEFI).
  • Current understanding of fever's physiological role, optimal measurement techniques, and interpretation of data from vaccine safety trials is limited.
  • Despite uncertainties, fever is generally a benign clinical sign.

Purpose of the Study:

  • To highlight the need for standardized definitions and assessment methods for fever in vaccine safety studies.
  • To improve the interpretation of fever data in vaccine safety trials and immunization safety surveillance.
  • To enhance the understanding of fever's significance as an adverse event following immunization.

Main Methods:

  • Review of existing literature on fever definition, measurement, and its role as an adverse event following immunization.

Related Experiment Videos

  • Analysis of challenges in comparing fever data across different vaccine safety studies.
  • Discussion of the implications of non-standardized fever assessment in public health surveillance.

    • Main Results:

    • The definition of fever has historical roots but lacks current standardization for comparative analysis.
    • Variability in body temperature measurement sites and methods complicates data interpretation.
    • Lack of standardized assessment hinders a clear understanding of fever's impact as an AEFI.

    Conclusions:

    • Standardizing fever definition and measurement is crucial for vaccine safety studies.
    • Comparable data will lead to a better understanding of fever's role and significance as an AEFI.
    • Improved understanding supports more accurate vaccine safety surveillance and public health decision-making.